The antiobesity drug orlistat [`Xenical'; Roche] has been granted priority review status

Source: Inpharma, Volume 1, Number 1294, 2001 , pp. 22-22(1)

Publisher: Adis International

Keywords: Orlistat, therapeutic use; Regulatory-process; Obesity, treatment; Type-2-diabetes-mellitus

Language: English

Document Type: Short communication

Links for this article

http://www.ingentaconnect.com/adis/inp/2001/00000001/00001294/art00034
http://openurl.ingenta.com/content?genre=article&issn=11738324&volume=1&issue=1294&spage=22&epage=22